Cytoplasmic viscosity is a potential biomarker for metastatic breast cancer cells

被引:5
|
作者
Dessard, Marie [1 ,2 ]
Manneville, Jean-Baptiste [1 ]
Berret, Jean-Francois [1 ]
机构
[1] Univ Paris Cite, CNRS, Matiere & Syst Complexes, F-75013 Paris, France
[2] Aix Marseille Univ, INSERM, CIML, CNRS, F-13009 Marseille, France
来源
NANOSCALE ADVANCES | 2024年 / 6卷 / 06期
关键词
INTRACELLULAR MECHANICS; LIVING CELLS; RHEOLOGY; VISCOELASTICITY; TRANSFORMATION; DEFORMABILITY; ORGANIZATION; CARCINOMA; CORRELATE; DYNAMICS;
D O I
10.1039/d4na00003j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cellular microrheology has shown that cancer cells with high metastatic potential are softer compared to non-tumorigenic normal cells. These findings rely on measuring the apparent Young's modulus of whole cells using primarily atomic force microscopy. The present study aims to explore whether alternative mechanical parameters have discriminating features with regard to metastatic potential. Magnetic rotational spectroscopy (MRS) is employed in the examination of mammary epithelial cell lines: MCF-7 and MDA-MB-231, representing low and high metastatic potential, along with normal-like MCF-10A cells. MRS utilizes active micron-sized magnetic wires in a rotating magnetic field to measure the viscosity and elastic modulus of the cytoplasm. All three cell lines display viscoelastic behavior, with cytoplasmic viscosities ranging from 10 to 70 Pa s and elastic moduli from 30 to 80 Pa. It is found that the tumorigenic MCF-7 and MDA-MB-231 cells are softer than the MCF-10A cells, with a twofold decrease in the elastic modulus. To differentiate cells with low and high malignancy however, viscosity emerges as the more discriminating parameter, as MCF-7 exhibits a 5 times higher viscosity as compared to MDA-MB-231. These findings highlight the sensitivity of cytoplasmic viscosity to metastatic activity, suggesting its potential use as a mechanical marker for malignant cancer cells. Intracellular microrheology reveals static viscosity, not elastic modulus, as a potential marker for invasive and metastatic cancer cells.
引用
收藏
页码:1727 / 1738
页数:12
相关论文
共 50 条
  • [21] Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells
    Gao, Liucun
    Xie, Huahong
    Dong, Lihou
    Zou, Jia
    Fu, Jie
    Gao, Xin
    Ou, Lun
    Xiang, Shensi
    Song, Haifeng
    MOLECULAR MEDICINE REPORTS, 2014, 9 (03) : 1032 - 1036
  • [22] Expression of a novel factor in human breast cancer cells with metastatic potential
    Ree, AH
    Tvermyr, M
    Engebraaten, O
    Rooman, M
    Rosok, O
    Hovig, E
    Meza-Zepeda, LA
    Bruland, OS
    Fodstad, O
    CANCER RESEARCH, 1999, 59 (18) : 4675 - 4680
  • [23] CIRCULATING TUMOR DNA IS A BIOMARKER OF METASTATIC BREAST CANCER
    不详
    CANCER DISCOVERY, 2013, 3 (05) : 482 - 482
  • [24] Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
    Dharanija Madhavan
    Markus Wallwiener
    Karin Bents
    Manuela Zucknick
    Juliane Nees
    Sarah Schott
    Katarina Cuk
    Sabine Riethdorf
    Andreas Trumpp
    Klaus Pantel
    Christof Sohn
    Andreas Schneeweiss
    Harald Surowy
    Barbara Burwinkel
    Breast Cancer Research and Treatment, 2014, 146 : 163 - 174
  • [25] Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
    Madhavan, Dharanija
    Wallwiener, Markus
    Bents, Karin
    Zucknick, Manuela
    Nees, Juliane
    Schott, Sarah
    Cuk, Katarina
    Riethdorf, Sabine
    Trumpp, Andreas
    Pantel, Klaus
    Sohn, Christof
    Schneeweiss, Andreas
    Surowy, Harald
    Burwinkel, Barbara
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (01) : 163 - 174
  • [26] Prospective study with circulating tumor cells as potential prognosis biomarker in metastatic colorectal cancer
    Souza E Silva, Virgilio
    Abdallah, Emne Ali
    Lopes de Mello, Celso Abdon
    Tariki, Milena Shizue
    Calsavara, Vinicius Fernando
    Chinen, Ludmilla T. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer
    Arellano-Garcia, Martha E.
    Li, Roger
    Liu, Xiaojun
    Xie, Yongming
    Yan, Xiaofei
    Loo, Joseph A.
    Hu, Shen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (09): : 3106 - 3121
  • [28] Pleiotrophin as a potential biomarker in breast cancer patients
    Ma, Jiequn
    Kong, Ying
    Nan, Haocheng
    Qu, Shengyang
    Fu, Xiao
    Jiang, Lili
    Wang, Wenjuan
    Guo, Hui
    Zhao, Shounian
    He, Jianjun
    Nan, Kejun
    CLINICA CHIMICA ACTA, 2017, 466 : 6 - 12
  • [29] Circulating CYTOR as a Potential Biomarker in Breast Cancer
    Moradi, Mohammad-Taher
    Hatami, Reza
    Rahimi, Zohreh
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2020, 9 (01) : 83 - 89
  • [30] Drebrin is a potential diagnostic biomarker for breast cancer
    Chen, Wenjun
    Liu, Guoping
    Jin, Mei
    Ju, Peixin
    Xu, Jianfang
    Zhang, Yong
    Zhang, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (12): : 23598 - 23604